1 / 11

Avastin Industry (Microvascular Complications of Diabetes) S

The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic retinopathy segment of the market has recently seen rapid uptake of novel anti-VEGF therapies and is experiencing a strong growth. On the other hand, the diabetic neuropathy and nephropathy segments face the barrier in and increasing number of generic competitors. Avastin (bevacizumab) is a recombinant humanized IgG1 mAb that specifically binds to VEGF-A, thereby preventing the interaction of VEGF-A with its receptors on the surface of endothelial cells. Through VEGF-A inhibition, Avastin inhibits angiogenesis, and is indicated for the adjunctive treatment of metastatic colorectal cancer as well as for other types of cancer.

marygarcia
Download Presentation

Avastin Industry (Microvascular Complications of Diabetes) S

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Avastin (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022byGlobalData Explore all reports for “Diabetes Therapeutics” market @ http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/diabetes-therapeutics © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  2. Avastin (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022 The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic retinopathy segment of the market has recently seen rapid uptake of novel anti-VEGF therapies and is experiencing a strong growth. On the other hand, the diabetic neuropathy and nephropathy segments face the barrier in and increasing number of generic competitors. Sample of the Report is available at http://www.rnrmarketresearch.com/contacts/request-sample?rname=147160 . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  3. Avastin (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022 Avastin (bevacizumab) is a recombinant humanized IgG1 mAb that specifically binds to VEGF-A, thereby preventing the interaction of VEGF-A with its receptors on the surface of endothelial cells. Through VEGF-A inhibition, Avastin inhibits angiogenesis, and is indicated for the adjunctive treatment of metastatic colorectal cancer as well as for other types of cancer. Sample of the Report is available at http://www.rnrmarketresearch.com/contacts/request-sample?rname=147160 . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  4. Avastin (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022 Scope Overview of MCD, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape. Detailed information on Avastin including product description, safety and efficacy profiles as well as a SWOT analysis. Sales forecast for Avastin for the top seven countries from 2012 to 2022. Sales information covered for the US, France, Germany, Italy, Spain, the UK and Japan. Inquire to get Discount on the report http://www.rnrmarketresearch.com/contacts/discount?rname=147160 . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  5. Avastin (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022 Reasons to buy Understand and capitalize by identifying products that are most likely to ensure a robust return Stay ahead of the competition by understanding the changing competitive landscape for MCD Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential Make more informed business decisions from insightful and in-depth analysis of Avastin performance Obtain sales forecast for Avastin from 2012-2022 in top seven countries (the US, France, Germany, Italy, Spain, the UK and Japan) PDF Of the Report is available at http://www.rnrmarketresearch.com/contacts/request-sample?rname=147160 . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  6. Avastin (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022 Table of Contents 1 Table of Contents1 Table of Contents 61.1 List of Tables 81.2 List of Figures 8 2 Introduction 92.1 Catalyst 92.2 Related Reports 10 Sample of the Report is available at http://www.rnrmarketresearch.com/contacts/request-sample?rname=147160 . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  7. Avastin (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022 3 Disease Overview 123.1 Etiology and Pathophysiology 143.1.1 Diabetic Nephropathy 143.1.2 Diabetic Retinopathy 163.1.3 Diabetic Neuropathy 173.2 Prognosis 183.3 Quality of Life 193.4 Symptoms 20 4 Disease Management 214.1 Treatment Overview 214.1.1 Diagnosis and Referrals 214.1.2 Screening 234.1.3 Treatment Guidelines 24 Inquire to get Discount on the report http://www.rnrmarketresearch.com/contacts/discount?rname=147160 . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  8. Avastin (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022 5 Competitive Assessment 325.1 Overview 325.2 Strategic Competitor Assessment 33 6 Avastin (bevacizumab) 376.1 Overview 376.2 Efficacy 386.3 Safety 396.4 SWOT Analysis 406.5 Forecast 41 Sample of the Report is available at http://www.rnrmarketresearch.com/contacts/request-sample?rname=147160 . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  9. Avastin (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022 7 Appendix 427.1 Bibliography 427.2 Abbreviations 477.3 Methodology 507.4 Forecasting Methodology 507.4.1 Diagnosed Patients 507.4.2 Percent Drug-Treated Patients 517.4.3 General Pricing Assumptions 517.4.4 Individual Drug Assumptions 527.4.5 Generic Erosion 527.5 Physicians and Specialists Included in this Study 537.6 About the Authors 557.6.1 Analyst II - CVMD 557.6.2 Therapy Director - CVMD and Infectious Disease 557.6.3 Global Head of Healthcare 567.7 About researcher 577.8 Disclaimer 57 PDF Of the Report is available at http://www.rnrmarketresearch.com/contacts/request-sample?rname=147160 . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  10. Avastin (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022 Table 1: Risk Factors for MCD 14Table 2: Symptoms of MCD 20Table 3: Diagnostic Tests and Typical Criteria for MCD 22Table 4: Treatment Guidelines for MCD 25Table 5: Most Prescribed Drugs for MCD by Class in the 7MM, 2012 28Table 6: Leading Drug Treatments for MCD, 2013 35Table 7: Product Profile - Avastin 38Table 8: Avastin SWOT Analysis, 2013 40Table 9: Global Sales Forecasts ($m) for Avastin, 2012-2022 41Table 10: Number of High-Prescribing Physicians Surveyed 54 List of Figures Figure 1: Potential Mechanisms of Diabetes-Induced Microvascular Complications 13Figure 2: General Treatment Algorithms for MCD 26 The report contains a list of tables and figures describing various market and research related to the industry. Inquire to get Discount on the report http://www.rnrmarketresearch.com/contacts/discount?rname=147160 . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  11. Avastin (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022 For more details contact Mr. PriyankTiwari:sales@rnrmarketresearch.com/ +18883915441 RnR Market Research RnRMarketResearch.com, an online repository of market  research reports, offers in-depth analysis of over 5000 market segments. RnR  Market Research library has syndicated reports by leading market research  publishers across the globe. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

More Related